{"id":53,"date":"2023-11-06T10:45:33","date_gmt":"2023-11-06T10:45:33","guid":{"rendered":"https:\/\/liveunlimitedpku-dev-001.azurewebsites.net\/en-gb\/liveunlimited\/?page_id=53"},"modified":"2024-05-14T18:58:44","modified_gmt":"2024-05-14T18:58:44","slug":"what-needs-to-change","status":"publish","type":"page","link":"https:\/\/pku.biomarin.com\/en-gb\/liveunlimited\/what-needs-to-change\/","title":{"rendered":"What needs to change?"},"content":{"rendered":"
\n
<\/div>\n\t
<\/div>\n \t
<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t \t\t\t\t Life is complicated when you don’t have the tools you need<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
WHAT NEEDS TO CHANGE?\n<\/h1>\n\t\t\t\t\t\t\t\t\t\t\t\t
We\u2019re calling for consistent provision of adult metabolic specialists, dieticians and psychological support for every adult with PKU in Europe.<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n
\n
\n
\n \n
\n
PKU can have a significant impact on a person\u2019s quality of life, but because the condition is rare and not widely known about, it is not currently being prioritised by European health authorities1<\/sup>.<\/h2>\n
We have now reached a new era in PKU, where the first adults diagnosed at birth through newborn screening face managing their condition throughout adulthood. This brings new challenges, and we urgently need to find ways to evolve care and support the needs of everyone living with PKU.<\/p>\n
Building on research and recommendations delivered by the European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria (ESPKU) in 2015 and the most recent European clinical guidelines in 2017, the Live Unlimited campaign is calling for specific aspects of care for adults with PKU to be improved to adequately reflect the lifelong nature of the condition.<\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n